Hun Jung
jhun@astonsci.com
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hun Jung as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:13 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05794659 · Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian CancerAston Sci. Inc. · not yet recruiting · Advanced Ovarian Cancer · study director
- Ph2NCT05771584 · Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric CancerAston Sci. Inc. · active not recruiting · Gastric Cancer · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:13 UTC. The ranking covers the 200 most relevant of 433 PubMed records, and a shared surname and initials can bring in a namesake. All 433 on PubMed
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.Nat Med · 20181,396 citationsRCR 45.0
- Basal insulin and cardiovascular and other outcomes in dysglycemia.N Engl J Med · 20121,228 citationsRCR 37.4
- n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.N Engl J Med · 2012722 citationsRCR 22.3
- Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.N Engl J Med · 2016689 citationsRCR 25.0
- Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.N Engl J Med · 2016473 citationsRCR 17.6
- Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder.J Affect Disord · 2007303 citationsRCR 8.6
- Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.N Engl J Med · 2016286 citationsRCR 9.9
- Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis.N Engl J Med · 2014207 citationsRCR 7.3
- Endoscopic sphincterotomy plus large-balloon dilation versus endoscopic sphincterotomy for removal of bile-duct stones.Gastrointest Endosc · 2007184 citationsRCR 7.6
- Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04).J Clin Oncol · 2024180 citationsRCR 18.8